New study below [1] [2].
"The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and circulating tumor cells (CTCs) have been associated with survival in castration-resistant prostate cancer (CRPC). However, no study has examined the prognostic value of NLR and PLR in the context of CTCs."
"Among the 37 patients with detectable CTCs, those with a high NLR had significantly shorter OS {overall survival}".
"Compared to the patients with CTCs and low NLR, those with CTCs and high levels of NLR had a 3.79-fold risk of death "
See also: "Inflammation. [1] Neutrophil-to-Lymphocyte Ratio [NLR]" [3]
Subclinical inflammation is a killer, but can be countered.
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/340...
[2] Full text: bmccancer.biomedcentral.com...